Highnoon Laboratories (KAR:HINOON) Other Current Liabilities: ₨282 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KAR:HINOON Highnoon Laboratories Ltd KAR:HINOON
96 GF Score
Price ₨1,003.54
GF Value ₨1,030.52
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Highnoon Laboratories Other Current Liabilities?

Highnoon Laboratories KAR:HINOON +0.86% 96 Other Current Liabilities is ₨282 Mil as of Mar. 2026. GuruFocus rates KAR:HINOON with a GF Score™ of 96/100 and a GF Value™ of ₨1,030.52 (Fairly Valued). The stock has 3 warning signs investors should review.

Highnoon Laboratories's other current liabilities for the quarter that ended in Mar. 2026 was ₨282 Mil.

Highnoon Laboratories's quarterly other current liabilities declined from Sep. 2025 (₨927 Mil) to Dec. 2025 (₨782 Mil) and declined from Dec. 2025 (₨782 Mil) to Mar. 2026 (₨282 Mil).

Highnoon Laboratories's annual other current liabilities increased from Dec. 2023 (₨691 Mil) to Dec. 2024 (₨773 Mil) and increased from Dec. 2024 (₨773 Mil) to Dec. 2025 (₨782 Mil).

Highnoon Laboratories Other Current Liabilities Related Terms

Highnoon Laboratories Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Highnoon Laboratories's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Highnoon Laboratories Other Current Liabilities Chart

Highnoon Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 329.81 834.34 690.87 773.01 782.13

Highnoon Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 175.08 464.31 926.67 782.13 281.93
KAR:HINOON
96GF Score
Highnoon Laboratories Ltd KAR:HINOON
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Highnoon Laboratories Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ₨282 Mil mean?
Highnoon Laboratories (KAR:HINOON) has a Other Current Liabilities of ₨282 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Highnoon Laboratories.
Is Highnoon Laboratories' Other Current Liabilities too high?
Highnoon Laboratories' current Other Current Liabilities is ₨282 Mil. Overall, Highnoon Laboratories has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Highnoon Laboratories' Other Current Liabilities compare to LLY and JNJ?
Highnoon Laboratories' Other Current Liabilities of ₨282 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Highnoon Laboratories. Highnoon Laboratories's current Other Current Liabilities is ₨282 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Highnoon Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Highnoon Laboratories (KAR:HINOON) is currently considered Fairly Valued. The stock's GF Value™ is ₨1,030.52, compared to a current price of ₨1,003.54 — trading 2.6% below its estimated fair value. The current Other Current Liabilities is ₨282 Mil. Highnoon Laboratories' overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Highnoon Laboratories (KAR:HINOON), the current Other Current Liabilities is ₨282 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Highnoon Laboratories (KAR:HINOON) Overvalued in 2026?

Based on GuruFocus' analysis, Highnoon Laboratories stock appears to be undervalued. The current stock price of ₨1,003.54 is trading 2.6% below its estimated GF Value™ of ₨1,030.52. GuruFocus considers Highnoon Laboratories to be Fairly Valued.

Key valuation signals for KAR:HINOON:

  • Other Current Liabilities: ₨282 Mil
  • GF Value™: ₨1,030.52 vs. price of ₨1,003.54 (2.6% below fair value)
  • GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the KAR:HINOON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Highnoon Laboratories Business Description

Address Jail Road, 901-9th floor, Tricon Corporate Center 73-E, Lahore, PAK
Highnoon Laboratories Ltd is a company engaged in the manufacture, import, sale, and marketing of pharmaceutical and allied consumer products. It focuses on the alimentary tract and metabolism, antihistamines, anti-infectives, cardiovascular, endocrine, hematology, musculoskeletal, nervous system, parasitology, respiratory, and urinary. Its products include AIRTAL (Aceclofenac); ARIA (ketotifen); ARTECXCIN, and artrodar (diacerein). Its other products include Asthavent, AXESOME, Bezisox, Betatec, and many more.
96GF Score

Get the complete analysis for KAR:HINOON

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨1,003.54
Price
₨1,030.52
GF Value